DAPASUG-10
| Brand | DAPASUG-10 |
|---|---|
| Composition | Dapagliflozin 10mg |
| Packing | 10x14 |
| Pack Type | Tab |
For pharmaceutical trade buyers, not patient or consumer sales. This record reproduces company product information, not medical advice. Current product availability and terms are confirmed by Intra Life.
Enquire about DAPASUG-10Indication
For type 2 diabetes mellitus, alongside diet and exercise to improve blood glucose control.
Mechanism of action
Dapagliflozin inhibits SGLT2 in the proximal renal tubules. This reduces glucose reabsorption and increases urinary glucose excretion.
For pharmaceutical trade information, not a patient-specific prescription. Use the current approved product insert and the prescribing clinician's directions.
DAPASUG-10 for B2B enquiries
Distributors, stockists, medical stores, hospitals and PCD franchise buyers can share their city, quantity and product requirements. Ask the team for current supply, packing and trade terms.
Ask for trade details on WhatsAppKeep exploring
Browse related brand searches · All published products · Browse divisions
Explore products with a matching ingredient term
For catalogue browsing only, not substitutions. Formulations and strengths differ.
SUGALIFE-D 10/60
LINASUG-DP Tablet
DAPASUG-SM-500
DAPASUG-M